Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Adare Pharmaceuticals Press Releases

Eurand Initiates the Second of Two Phase III Studies for EUR-1008 In Patients With Pancreatic Insufficiency

31 May 2006

Make an enquiry

Follow this company to receive notifications when they update


Go Top